Neumora Therapeutics' Upcoming Investor Conferences
As the landscape of biopharmaceutical innovation continues to evolve, Neumora Therapeutics, Inc. (NASDAQ: NMRA) stands at the forefront. This clinical-stage biopharmaceutical company, dedicated to tackling some of the most significant medical challenges of our time, has announced its participation in two important investor conferences this November. These events present an excellent opportunity for the company to showcase its innovative pipeline designed to address various prevalent diseases.
Details of the Events
Neumora will contribute to valuable discussions at the following conferences:
Guggenheim 2nd Annual Healthcare Innovation Conference
Management representatives from Neumora will join a fireside chat on the agenda of this prestigious event, taking place on a notable day in November at 2:30 p.m. ET. The conference promises to be an engaging gathering for leaders and innovators in healthcare.
Stifel 2025 Healthcare Conference
The company is also scheduled to participate in another pivotal fireside chat during this esteemed conference. Set to occur on the same week at 2:00 p.m. ET, this meeting aims to highlight industry developments and foster connections among stakeholders in the healthcare sector.
Live Webcasts Available
For those unable to attend these conferences in person, Neumora will facilitate a live webcast for each event. Interested parties can access these webcasts via the events and presentations section of the company's website. Moreover, recordings will be archived for 30 days, ensuring that information is available for all stakeholders to review and enjoy.
About Neumora Therapeutics
Founded with a bold vision, Neumora Therapeutics, Inc. has established itself as a leader in the development of therapies targeting brain diseases. The company's innovative pipeline includes seven unique programs aimed at addressing treatment gaps for a variety of underserved conditions. Through its research and development, Neumora seeks to redefine how neuroscience drugs are conceived and delivered, striving to improve the quality of life for patients globally.
Contact Information
For further inquiries or detailed information regarding the upcoming conferences and pipeline advancements, please reach out to:
Helen Rubinstein
Phone: 617-402-5700
Email: Helen.Rubinstein@neumoratx.com
Frequently Asked Questions
What does Neumora Therapeutics focus on?
Neumora specializes in developing biopharmaceuticals to treat brain diseases using innovative approaches.
When will Neumora participate in investor conferences?
Neumora will participate in investor conferences on November 10 and November 12.
How can I access the live webcasts of the events?
The live webcasts will be available on the events and presentations section of Neumora’s website.
Is there an archive for the webcasts?
Yes, a replay of the webcasts will be available and archived for up to 30 days following the events.
Who can I contact for more information?
You can contact Helen Rubinstein at 617-402-5700 or via email at Helen.Rubinstein@neumoratx.com for more information.